Gencyte Therapeutics, Inc. 

Developing next generation of CAR-T platform for cancer treatment.

OWNER

Chuhua (John) Zhong (See Profile)


Sector

Therapeutics

Stage

Discovery, Idea

Country

USA


Next-generation, proprietary CAR-T platform technology

It would feature higher efficacy, less toxicity, and better cost effectiveness than current approaches.

Pantent pending

IP Type Status Time Countries Link Coverage
PCT Pending
  • USA

This information is confidential, do not share or copy.

Under evaluation at least till: 24th March

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2021 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar